de State Street Cytokinetics CYTK Historial de posiciones en acciones
Compró
Mantenido
Vendió
| Trimestre | Valor de mercado | Estado | Núm. de acciones |
Cambio en la participación | Valor operado | Peso en el portafolio | Posición de la cartera | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | USD 553 M | Comprar |
6,494,233
+749,040
| +13% | +USD 53.8 M | 0.02% | 563 |
|
|
2026
Q1 | USD 379 M | Vender |
5,745,193
-80,102
| -1% | -USD 5.09 M | 0.01% | 647 |
|
|
2025
Q4 | USD 370 M | Comprar |
5,825,295
+207,961
| +4% | +USD 12.9 M | 0.01% | 654 |
|
|
2025
Q3 | USD 309 M | Vender |
5,617,334
-755,419
| -12% | -USD 31.1 M | 0.01% | 724 |
|
|
2025
Q2 | USD 211 M | Comprar |
6,372,753
+287,752
| +5% | +USD 10 M | 0.01% | 875 |
|
|
2025
Q1 | USD 245 M | Vender |
6,085,001
-82,339
| -1% | -USD 3.78 M | 0.01% | 785 |
|
|
2024
Q4 | USD 290 M | Vender |
6,167,340
-290,984
| -5% | -USD 15.1 M | 0.01% | 733 |
|
|
2024
Q3 | USD 341 M | Vender |
6,458,324
-90,212
| -1% | -USD 5.03 M | 0.01% | 657 |
|
|
2024
Q2 | USD 355 M | Comprar |
6,548,536
+2,028,178
| +45% | +USD 122 M | 0.02% | 602 |
|
|
2024
Q1 | USD 317 M | Vender |
4,520,358
-1,373,000
| -23% | -USD 106 M | 0.01% | 660 |
|
|
2023
Q4 | USD 492 M | Comprar |
5,893,358
+618,872
| +12% | +USD 22.4 M | 0.02% | 516 |
|
|
2023
Q3 | USD 155 M | Comprar |
5,274,486
+182,906
| +4% | +USD 6.09 M | 0.01% | 905 |
|
|
2023
Q2 | USD 166 M | Comprar |
5,091,580
+337,680
| +7% | +USD 12.5 M | 0.01% | 891 |
|
|
2023
Q1 | USD 167 M | Vender |
4,753,900
-291,014
| -6% | -USD 11.9 M | 0.01% | 862 |
|
|
2022
Q4 | USD 231 M | Comprar |
5,044,914
+789,789
| +19% | +USD 34 M | 0.01% | 695 |
|
|
2022
Q3 | USD 206 M | Vender |
4,255,125
-249,101
| -6% | -USD 12 M | 0.01% | 721 |
|
|
2022
Q2 | USD 177 M | Comprar |
4,504,226
+307,394
| +7% | +USD 12.4 M | 0.01% | 803 |
|
|
2022
Q1 | USD 154 M | Comprar |
4,196,832
+211,605
| +5% | +USD 7.52 M | 0.01% | 1002 |
|
|
2021
Q4 | USD 182 M | Vender |
3,985,227
-325,061
| -8% | -USD 12.5 M | 0.01% | 915 |
|
|
2021
Q3 | USD 154 M | Comprar |
4,310,288
+59,502
| +1% | +USD 1.75 M | 0.01% | 982 |
|
|
2021
Q2 | USD 84.1 M | Comprar |
4,250,786
+108,816
| +3% | +USD 2.56 M | ﹤0.01% | 1436 |
|
|
2021
Q1 | USD 96.3 M | Vender |
4,141,970
-498,953
| -11% | -USD 10.7 M | 0.01% | 1263 |
|
|
2020
Q4 | USD 96.4 M | Comprar |
4,640,923
+860,663
| +23% | +USD 15.7 M | 0.01% | 1173 |
|
|
2020
Q3 | USD 81.8 M | Comprar |
3,780,260
+739,228
| +24% | +USD 17.3 M | 0.01% | 1106 |
|
|
2020
Q2 | USD 71.7 M | Comprar |
3,041,032
+355,470
| +13% | +USD 6.67 M | 0.01% | 1194 |
|
|
2020
Q1 | USD 31.7 M | Comprar |
2,685,562
+145,796
| +6% | +USD 1.86 M | ﹤0.01% | 1545 |
|
|
2019
Q4 | USD 26.9 M | Comprar |
2,539,766
+218,887
| +9% | +USD 2.25 M | ﹤0.01% | 1930 |
|
|
2019
Q3 | USD 26.4 M | Vender |
2,320,879
-95,635
| -4% | -USD 1.2 M | ﹤0.01% | 1879 |
|
|
2019
Q2 | USD 27.2 M | Comprar |
2,416,514
+374,437
| +18% | +USD 3.61 M | ﹤0.01% | 1898 |
|
|
2019
Q1 | USD 16.5 M | Comprar |
2,042,077
+126,115
| +7% | +USD 927 k | ﹤0.01% | 2168 |
|
|
2018
Q4 | USD 12.1 M | Vender |
1,915,962
-85,600
| -4% | -USD 628 k | ﹤0.01% | 2327 |
|
|
2018
Q3 | USD 19.7 M | Vender |
2,001,562
-43,739
| -2% | -USD 351 k | ﹤0.01% | 2190 |
|
|
2018
Q2 | USD 17 M | Vender |
2,045,301
-316,311
| -13% | -USD 2.63 M | ﹤0.01% | 2241 |
|
|
2018
Q1 | USD 17 M | Vender |
2,361,612
-354,360
| -13% | -USD 3.04 M | ﹤0.01% | 2163 |
|
|
2017
Q4 | USD 22.1 M | Comprar |
2,715,972
+880,457
| +48% | +USD 10 M | ﹤0.01% | 1980 |
|
|
2017
Q3 | USD 26.6 M | Comprar |
1,835,515
+161,180
| +10% | +USD 2.2 M | ﹤0.01% | 1819 |
|
|
2017
Q2 | USD 20.3 M | Comprar |
1,674,335
+741,909
| +80% | +USD 10.3 M | ﹤0.01% | 1969 |
|
|
2017
Q1 | USD 12 M | Comprar |
932,426
+34,678
| +4% | +USD 405 k | ﹤0.01% | 2268 |
|
|
2016
Q4 | USD 10.9 M | Vender |
897,748
-75,452
| -8% | -USD 801 k | ﹤0.01% | 2290 |
|
|
2016
Q3 | USD 8.94 M | Comprar |
973,200
+349,954
| +56% | +USD 3.65 M | ﹤0.01% | 2245 |
|
|
2016
Q2 | USD 5.91 M | Comprar |
623,246
+77,786
| +14% | +USD 638 k | ﹤0.01% | 2499 |
|
|
2016
Q1 | USD 3.84 M | Vender |
545,460
-255,751
| -32% | -USD 1.87 M | ﹤0.01% | 2687 |
|
|
2015
Q4 | USD 8.38 M | Comprar |
801,211
+250,173
| +45% | +USD 2.45 M | ﹤0.01% | 2290 |
|
|
2015
Q3 | USD 3.69 M | Comprar |
551,038
+1,423
| +0.3% | +USD 9.7 k | ﹤0.01% | 2667 |
|
|
2015
Q2 | USD 3.69 M | Comprar |
549,615
+14,282
| +3% | +USD 93.7 k | ﹤0.01% | 2795 |
|
|
2015
Q1 | USD 3.63 M | Comprar |
535,333
+26,166
| +5% | +USD 195 k | ﹤0.01% | 2744 |
|
|
2014
Q4 | USD 4.08 M | Comprar |
509,167
+5,677
| +1% | +USD 24.4 k | ﹤0.01% | 2675 |
|
|
2014
Q3 | USD 1.78 M | Comprar |
503,490
+10,122
| +2% | +USD 42.5 k | ﹤0.01% | 3067 |
|
|
2014
Q2 | USD 2.36 M | Comprar |
493,368
+4,194
| +0.9% | +USD 25.6 k | ﹤0.01% | 2986 |
|
|
2014
Q1 | USD 4.65 M | Comprar |
489,174
+76,964
| +19% | +USD 696 k | ﹤0.01% | 2606 |
|
|
2013
Q4 | USD 2.68 M | Comprar |
412,210
+34,523
| +9% | +USD 227 k | ﹤0.01% | 2929 |
|
|
2013
Q3 | USD 2.87 M | Comprar |
377,687
+88,953
| +31% | +USD 954 k | ﹤0.01% | 2862 |
|
|
2013
Q2 | USD 3.34 M | Comprar |
+288,734
| Nuevas | +USD 2.27 M | ﹤0.01% | 2688 |
|
Otros fondos que tienen CYTK en su cartera
Posición de State Street en CYTK: resumen de T2 2026
State Street aumentó su participación en Cytokinetics (CYTK) en 13% durante T2 2026, al comprar aproximadamente USD 53.8 M y elevar la posición a 6,494,233 acciones con un valor de USD 553 M. La posición representa 0.02% de la cartera y ocupa el puesto #563.
State Street reportó por primera vez una posición en CYTK en T2 2013 y la ha mantenido durante 53 trimestres desde entonces. Al cierre de T2 2026, 486 fondos que sigue Wall St. Rank mantienen una posición en CYTK.
- Al cierre de T2 2026, State Street tenía 6,494,233 acciones de Cytokinetics con un valor de USD 553 M.
- State Street compró 749,040 acciones de Cytokinetics en T2 2026, por un monto estimado de USD 53.8 M.
- Cytokinetics representó 0.02% de la cartera de State Street en T2 2026 y fue su posición número 563.
- State Street reportó por primera vez una posición en Cytokinetics en T2 2013 y la ha mantenido durante 53 trimestres desde entonces.
- Al cierre de T2 2026, 486 fondos que sigue Wall St. Rank tenían Cytokinetics en cartera.
Según el Informe 13F de State Street correspondiente a T2 2026, presentado el 7 ago 2026.